A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 468,900 shares of NMTC stock, worth $384,498. This represents 0.0% of its overall portfolio holdings.

Number of Shares
468,900
Holding current value
$384,498
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$0.43 - $0.87 $201,627 - $407,943
468,900 New
468,900 $318,000

Others Institutions Holding NMTC

About NEUROONE MEDICAL TECHNOLOGIES Corp


  • Ticker NMTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,209,200
  • Market Cap $13.3M
  • Description
  • NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...
More about NMTC
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.